“…This includes for intrauterine adhesion ( Yao et al, 2019 ), liver fibrosis ( Li et al, 2012 ), acute lung injury (ALI) ( Xiao et al, 2020 ), and cancer [including colorectal ( Zhang X. et al, 2020 ), liver ( Chen et al, 2018 ), thyroid ( Hardin et al, 2018 ), and lung ( Zhao et al, 2018 )]. In the majority of these studies, MSC-derived exosomes were used [including from bone marrow ( Yao et al, 2019 ) and umbilical cord ( Li et al, 2012 ; Zhao et al, 2018 )], though others involved exosomes derived directly from carcinomas ( Chen et al, 2018 ; Zhang X. et al, 2020 ) or stem-like cells ( Hardin et al, 2018 ). Like inorganic NPs, most of the exosomes involved no additional API and instead relied on the intrinsic EMT-inhibition of the derived surface proteins.…”